[1] |
Ferlay JEM, Lam F, Colombet M, et al. Global cancer observatory: cancer today. Lyon, france: international agency for research on cancer.[EB/OL].(2020-03-02)[2021-08-27].
URL
|
[2] |
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CA: A Cancer Journal for Clinicians, 2020, 70(3): 145-164.
|
[3] |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
[4] |
National Cancer Institute. Cancer Stat Facts: Colorectal Cancer[EB/OL].(2017-02-07) [2021-08-27].
URL
|
[5] |
Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies[J]. Bmj, 2014, 348: g2467.
|
[6] |
NdPilonis, Bugajski M, Wieszczy P, et al. Long-term colorectal cancer incidence and mortality after a single negative screening colonoscopy [J]. Ann Intern Med, 2020, 173(2): 81-91.
|
[7] |
Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer[J]. N Engl J Med, 2013, 369(12): 1106-1114.
|
[8] |
CHIU HM, CHEN SL, YEN AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program[J]. Cancer, 2015, 121(18): 3221-3229.
|
[9] |
Lin JS, Perdue LA, Henrikson NB, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force[J]. JAMA, 2021, 325(19): 1978-1997.
|
[10] |
王红, 黄慧瑶, 刘成成, 等. 我国结直肠癌筛查卫生经济学证据系统更新:2009-2018[J]. 中华流行病学杂志, 2020, 41(3): 429-435.
|
[11] |
健康中国行动推进委员会. 健康中国行动(2019-2030年)[EB/OL].(2019-07-15)[2021-08-27].
URL
|
[12] |
Guo F, De Brabander I, Francart J, et al. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme[J]. Br J Cancer, 2020, 122(7): 1109-1117.
|
[13] |
Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis[J]. Prev Med, 2012, 55(2): 87-92.
|
[14] |
Tinmouth J, Lansdorp-vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know[J]. Gut, 2015, 64(8): 1327-1337.
|
[15] |
国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组. 中国结直肠癌筛查与早诊早治指南(2020,北京)[J]. 中华肿瘤杂志, 2021, 43(1): 16-38.
|
[16] |
Allison JE, Fraser CG, Halloran SP, et al. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT)[J]. Gut Liver, 2014, 8(2): 117-130.
|
[17] |
Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening[J]. N Engl J Med, 2014, 370(14): 1287-1297.
|
[18] |
关旭, 马晨曦, 王炜, 等. 多靶点粪便FIT-DNA检测技术在结直肠癌患者、配偶及一级亲属筛查中的应用研究[J/OL]. 中华结直肠疾病电子杂志, 2021, 10(3): 237-242.
|
[19] |
Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy[J]. N Engl J Med, 2012, 366(25): 2345-2357.
|
[20] |
U.S. Centers for Disease Control and Prevention. Colorectal Cancer Statistics[EB/OL]. (2021-07-08) [2021-08-27].
URL
|
[21] |
Cancer Research UK. Bowel Cancer Screening Coverage and Uptake, UK, FY2012-2015[EB/OL].(2021-07-31) [2021-08-27].
URL
|
[22] |
Singh H, Bernstein CN, Samadder JN, et al. Screening rates for colorectal cancer in Canada: a cross-sectional study[J]. CMAJ Open, 2015, 3(2): E149-157.
|
[23] |
Australian Institute of Health and Welfare. Bowel cancer screening in Australia[EB/OL].(2020-07-31) [2021-08-27].
URL
|
[24] |
厚生労働省. 2019年国民生活基礎調査の概況[EB/OL].(2010-07-17) [2021-08-27].
URL
|
[25] |
Hong S, Lee YY, Lee J, et al. Trends in cancer screening rates among korean men and women: results of the Korean national cancer screening survey, 2004—2018[J]. Cancer Res Treat, 2021, 53(2): 330-338.
|
[26] |
衛生福利部國民健康署. 102年50-69歲民眾最近兩年內接受大腸癌篩檢率[EB/OL].(2016-04-15)[2021-08-27].
URL
|
[27] |
高乐, 于树青, 杨继春, 等. 全球结直肠癌筛查指南的质量评价[J]. 北京大学学报(医学版), 2019, 51(3): 176-183.
|
[28] |
田剑波, 温艳, 杨卓煜, 等. 全球结直肠癌筛查指南及共识质量评价[J]. 中华流行病学杂志, 2021, 42(2): 248-257.
|
[29] |
Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US preventive services task force recommendation statement [J]. JAMA, 2021, 325(19): 1965-1977.
|
[30] |
Shaukat A, Kahi CJ, Burke CA, et al. ACG Clinical Guidelines: Colorectal Cancer Screening 2021[J]. Am J Gastroenterol, 2021, 116(3): 458-479.
|
[31] |
吴春晓, 顾凯, 龚杨明, 等. 2015年中国结直肠癌发病和死亡情况分析[J]. 中国癌症杂志, 2020, 30(4): 241-245.
|
[32] |
Zheng GM, Choi BC, Yu XR, et al. Mass screening for rectal neoplasm in Jiashan County, China[J]. J Clin Epidemiol, 1991, 44(12): 1379-1385.
|
[33] |
杨金华, 沈飞琼, 薛峰, 等. 2007-2016年浙江省嘉善县结直肠癌筛查方案应用评价[J]. 中国肿瘤, 2020, 29(12): 919-924.
|
[34] |
陈万青, 李霓, 曹毛毛, 等. 2013-2017年中国城市癌症早诊早治项目基线结果分析[J]. 中国肿瘤, 2020, 29(1): 1-6.
|
[35] |
陈宏达, 李霓, 任建松, 等. 中国城市结直肠癌高危人群的结肠镜筛查依从性及其相关因素分析[J]. 中华预防医学杂志, 2018, 52(3): 231-237.
|
[36] |
安锦慧, 孙治平, 李云涛, 等. 我国结直肠癌筛查的影响因素文献分析及思考[J]. 中国全科医学, 2020, 23(23): 2877-2882.
|
[37] |
国家消化系统疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化内镜学分会, 等. 中国早期结直肠癌筛查流程专家共识意见(2019, 上海)[J]. 中华医学杂志, 2019, 99 (38): 2961-2970.
|
[38] |
王锡山. 中美结直肠癌流行病学特征及防诊治策略的对比分析[J/OL]. 中华结直肠疾病电子杂志, 2017, 6(6): 447-453.
|
[39] |
张愉涵, 陈宏达, 卢明, 等. 结直肠癌筛查和早期诊断生物标志物研究进展[J]. 中华流行病学杂志, 2021, 42(1): 142-148.
|
[40] |
Tepus M, Yau TO. Non-Invasive Colorectal Cancer Screening: An Overview[J]. Gastrointest Tumors, 2020, 7(3): 62-73.
|
[41] |
胡茜玥, 刘正, 王锡山. 结直肠癌筛查策略的研究现状与思考[J]. 中国全科医学, 2021, 24(33): 4165-4171.
|